T R A N S F U S I O N P R A C T I C E
A randomized controlled pilot study of adherence to transfusion
strategies in cardiac surgery
_323691..99
NadineShehata,LauraAlexandraBurns,HowardNathan,PaulHebert,GregoryM.T.Hare,
DeanFergusson,andC.DavidMazer
R
edbloodcell(RBC)transfusionratesarehighin
BACKGROUND:Itisimportanttodeterminethe cardiac surgery, in part due to the question of
optimalhemoglobin(Hb)concentrationforredblood whetherthesepatientsrequireahighertransfu-
cell(RBC)transfusionforpatientsundergoingcardiac sionthreshold.However,thereislittledirectevi-
surgerybecauseincreasedmortalityhasbeenassoci- dencetosupportthisassumption.Todatenorandomized
atedwiththeseverityofanemiaandexposuretoRBCs. controlled trial has assessed the optimal transfusion
Becauseadefinitivetrialwillrequirethousandsof thresholdordeterminedthecrossoverpointatwhichthe
patients,andbecausethereisvariabilityintransfusion risk of acute anemia exceeds that of RBC transfusion in
practices,apilotstudywasundertakentodetermine cardiacsurgicalpatients.
adherencetoproposedstrategies. In a retrospective study of seven Canadian centers,
STUDYDESIGNANDMETHODS:Asingle-centerpar- which included 11,812 cardiac surgical patients,1 44% of
allelrandomizedcontrolledpilottrialwasconductedin patientsreceivedoneormoreRBCunits,andtherangeof
high-riskcardiacpatientstoassessadherencetotwo patientstransfusedwas28%to60%.Inarecentstudyin
transfusionstrategies.Fiftypatientswererandomly
assignedeithertoa“restrictive”transfusionstrategy
(RBCsiftheirHbconcentrationwas70g/Lorlessintra-
operativelyduringcardiopulmonarybypass[CPB]and ABBREVIATIONS:CARE=CardiacAnesthesiaRiskScore;
75g/Lorlesspostoperatively)ora“liberal”transfusion CPB=cardiopulmonarybypass;IQR=interquartilerange;
strategy(RBCsiftheirHbconcentrationwas95g/Lor TRACS=TransfusionRequirementsafterCardiacSurgery.
lessduringCPBandlessthan100g/Lpostoperatively).
FromtheDepartmentsofMedicine,AnesthesiaandPhysiology,
RESULTS:Thepercentageofadherenceoverallwas
UniversityofToronto,LiKaShingKnowledgeInstitute,Division
84%intherestrictivearmand41%intheliberalarm.
ofHematologySt.Michael’sHospital;CentralOntarioRegion,
Twenty-two(88%)patientsweretransfused99unitsof
CanadianBloodServices,Toronto,Ontario;theDepartmentof
RBCsintheliberalgroupcomparedto13patients
Anesthesia,StMichael’sHospital,UniversityofToronto,
whoweretransfused50unitsintherestrictivegroup
(p<0.01).Therewerenosignificantdifferencesinindi- Toronto,Ontario;theDepartmentofAnesthesia,Universityof
Ottawa,Ottawa,Ontario;andtheDepartmentofCriticalCare,
vidualadverseoutcomes;however,moreadverse
GeneralCampus,andClinicalEpidemiology,OttawaHospital
eventsoccurredintherestrictivegroup(38vs.15,
p<0.01). ResearchInstitute,CMAJ,Ottawa,Ontario,Canada.
Addressreprintrequeststo:C.DavidMazer,St.Michael’s
CONCLUSION:Adherencetotheevaluatedinterven-
Hospital,30BondStreet,Toronto,Ontario,M5B1W8,Canada;
tionsisvitaltoallrandomizedcontrolledtrialsasithas
e-mail:mazerd@smh.ca.
thepotentialtoaffectoutcomes.Furtherpilotstudies
ThisstudywassupportedbyCanadianBloodServicesSPF
arerequiredtooptimizeenrollmentandtransfusion
XT00070.CanadianBloodServicesasafundingagencydidnot
adherencebeforeadefinitivestudyisconducted.
haveanyroleinthedesignandconductofthestudy;collection,
management,analysis,andinterpretationofthedataorprepa-
ration,review,andapprovalofthemanuscript.
ThisstudywasregisteredatClinicalTrials.gov
NCT00470444.
ReceivedforpublicationNovember17,2010;revision
receivedApril25,2011,andacceptedMay1,2011.
doi:10.1111/j.1537-2995.2011.03236.x
TRANSFUSION2012;52:91-99.
Volume52,January2012 TRANSFUSION 91
SHEHATAETAL.
theUnitedStates,in100,000patientsundergoingprimary MATERIALS AND METHODS
elective coronary artery bypass graft surgery (CABG) the
Study design
frequency of RBC transfusion rates ranged from 7.8% to
92.8%.2Becausemorbidityandmortalitymaybedepen- A single-center open-labeled parallel randomized con-
dent on the severity of anemia and exposure to trolledpilottrialoftwotransfusionstrategiesinpatients
transfusions,3-8 it is essential to determine the optimal having elective cardiac surgery was conducted to deter-
thresholdhemoglobin(Hb)concentrationatwhichphy- mine enrollment and adherence to Hb concentrations
sicians should be transfusing these patients, to reduce used for transfusion triggers. The randomization
morbidity and mortality. This is particularly important sequence was created using permuted blocks of four
because the efficacy of liberal transfusion has not been stratified by age and the Cardiac Anesthesia Risk Score
establishedincardiacsurgicalpatientsandRBCtransfu- (CARE)score.17Opaquesequentialsealedenvelopeswere
sion has been associated with an increased risk of renal used and opened at the start of surgery. The allocation
failure(oddsratio[OR],2.1;95%confidenceinterval[CI], sequence was generated by an independent statistician
1.9-2.3),cardiaccomplications(OR,1.6;95%CI,1.5-1.6), at the Ottawa Methods Centre of the Ottawa Hospital
neurologicevents(OR,1.4;95%CI,1.3-1.4),andmortality Research Institute. The research coordinator enrolled
(OR,1.8;95%CI,1.7-1.9).8 participants and assigned participants to the trans-
Despitethelargenumberofpublishedclinicalstudies fusionstrategies.Thestudywasapprovedbytheresearch
whichhaveattemptedtodeterminetheoptimalHbcon- ethics board at St Michael’s Hospital and written in-
centrationatwhichtotransfusecardiacsurgicalpatients, formed consent was obtained from all patients before
noclearconsensushasemergedtoguideclinicalpractice. randomization.
Retrospective analyses have demonstrated increased Eligibleparticipantswereidentifiedinthepreopera-
morbidityandmortalitynearpreoperativeHbvaluesless tive clinic or hospital ward at St Michael’s Hospital
than 120g/L5,9 and at intraoperative Hb values ranging (Toronto,Ontario,Canada)from2007to2010.StMicha-
from 50 to 80g/L.10,11 Furthermore, patients having car- el’s Hospital is a university-affiliated tertiary care center
diovascular surgery with postoperative hematocrit (Hct) with approximately 1000 cardiac surgeries conducted
values of 34% (Hb concentrations of 110g/L) or higher yearly.
appeared to have an increase in morbidity.12The OR for Patients were allocated to one of two transfusion
myocardialinfarctionforthegroupwithaHctof34%or strategies.Patientsallocatedtoa“restrictive”transfusion
higherwas2.2(95%CI,1.04-4.76)comparedtothegroup strategyreceivedRBCtransfusionsiftheirHbwas70g/L
with a Hct of 24% or less.12 Yet, low Hb concentrations orlessduringcardiopulmonarybypass(CPB)and75g/L
have also been associated with adverse outcomes. Of orlesspostoperativelyafterbypass.Patientsallocatedtoa
27patientsundergoinginfrainguinalarterialbypasssur- “liberal”transfusionstrategyreceivedRBCtransfusionsif
gery,13 six patients who had symptomatic cardiac events theirHbconcentrationwas95g/Lorlessduringandless
hadaHctlevelbelow28%(aHbconcentrationofapproxi- than 100g/L after bypass. A lower Hb concentration for
mately93g/L). transfusion was used during CPB because metabolic
Because there is a wide range of Hb concentrations demandsarereducedduringanesthesiaandCPB.Whena
fortransfusion,andbecauseanemiaandtransfusionsare thresholdwasreached,eachgroupwastoreceive1unitof
independently associated with morbidity and mortality, RBCsadministeredatatimefollowedbydeterminationof
a definitive study is needed to determine the effect of theHbconcentration.Thetransfusionprotocolswereto
anemia.However,barrierstorecruitmentandadherence be adhered to from beginning of surgery until discharge
need to be identified so they can be addressed before a from hospital. Patients who had rapid blood loss were
larger definitive study.14 Clinical uncertainty resulting transfusedatthediscretionoftheattendingphysician.All
from1)apprehensionabouttransfusion,2)concernthat otheraspectsofpatientcarewerelefttothediscretionof
thetransfusionthresholdsarenotconsistentwithclinical theattendingphysicians.
practice, 3) not knowing which treatment is best, and 4) All outcomes were prespecified.The primary objec-
theconcernthatthedoctor–patientrelationshipcouldbe tivewastoassesstheenrollmentrateandoveralladher-
adverselyaffectedbytrialparticipationhavebeenshown ence to the transfusion strategies.We defined successful
to be deterrents in previous randomized controlled tri- adherence as adherence to the transfusion strategies in
als.15,16Therefore,apilotstudyisrequiredtodeterminethe 90%ofpatientsinmorethan90%oftheirdaysinhospital.
acceptability and feasibility of the transfusion strategies AdherencewasdefinedastransfusionofRBCsaccording
by physicians and patients because it is anticipated that totheHbthreshold.
enrollment and adherence will be low. The objective of Secondary outcomes included RBC transfusions,
this study was to determine enrollment and adherence clinical outcomes, and physiologic indicators of hypox-
with a protocol for Hb transfusion strategies in patients emia (mixed venous oxygen saturation). Clinical out-
havingcardiacsurgery. comesweredefinedas1)in-hospitalall-causemortality;
92 TRANSFUSION Volume52,January2012
ADHERENCETOTRANSFUSIONCRITERIA
2)acompositescoreofmorbidityconsistingofa)neuro- arterialpressure55to85mmHg,temperature33to35°C,
logic events defined as a new focal neurologic deficit and blood sugar 4 to 10mmol/L. Myocardial protection
lastingmorethan24hoursorirreversibleencephalopathy, wasachievedwithcoldbloodcrystalloidcardioplegia,and
b) dialysis-dependent renal failure or greater than 50% a“hot-shot”(250to500mL)wasdeliveredjustbeforethe
increase in creatinine, c) prolonged low cardiac output removal of the aortic cross-clamp. After separation from
state(i.e.,needfortwoormoreinotropesfor24hoursor CPB, heparin was reversed with protamine (approx.
more, intraaortic balloon pump or ventricular assist 10mg/1000 units of heparin) to normalize the activated
device for greater than 48h), and/or myocardial infarc- clottingtime.Postoperatively,patientsweremanagedina
tion,definedastroponinIlevelgreaterthan2.5mg/Land specialized cardiovascular intensive care unit with stan-
newQwavesonelectrocardiogramoraclinicaldiagnosis; dardizedprotocolsforearlyextubation(2-4hr).Intraop-
and3)hospitallengthsofstay.Weassembledanindepen- erative use of antifibrinolytic agents and cell salvage are
dentdatasafetymonitoringboardconsistingofacardiac routinelyusedatthestudysiteandwereusedatthedis-
anesthesiologist and a hematologist who reviewed the cretionofthesurgicalteam.
dataafter20patientswererecruited.
Statistical analysis
Study population Continuous variables were described as mean (standard
Eligible participants were adults patients undergoing deviation[SD])ormedians(withinterquartilerange[IQR])
cardiac surgery with a CARE score (a score for cardiac ifthedatawerenotnormallydistributed.Categoricalvari-
surgerypatientsusedtopredictmorbidityandmortality) ablesweredescribedasnumbersandpercentages.Weana-
of3or4,17orpatientsofadvancedagedefinedasgreater lyzedadherenceratesandalsoexaminedtheeffectofthe
than or equal to 80 years on the day of screening were transfusion strategies on the clinical outcomes using
included. A CARE score of 3 is defined as patients with univariate analysis, t test, and Mann-Whitney U test for
uncontrolled medical problems such as unstable angina continuous variables and chi-square test for categorical
treatedwithintravenousheparinornitroglycerin,useofa variables(ortheFisher’sexacttestiftheexpectednumber
preoperativeintraaorticballoonpump,heartfailurewith inanycellwaslessthan5).Thesignificancelevelwassetat
pulmonaryorperipheraledema,uncontrolledhyperten- a p value of less than 0.05 for all statistical analyses. All
sion, renal insufficiency (creatinine level greater than analyseswereconductedonanintent-to-treatbasis.
140mmol/L),debilitatingsystemicdiseases,orpatientsin A total sample size of 50 patients was estimated to
whomacomplexsurgeryisundertaken(i.e.,reoperation, producea97.5%CIequaltothesampleadherencepreva-
combined valve and coronary artery surgery, multiple lence plus or minus 8% when the true prevalence of
valve surgery, left ventricular aneurysmectomy, repair of adherence was hypothesized to be 90%. Therefore, 25
ventricular septal defect after myocardial infarction, or patientswererandomizedtotherestrictivegroupand25
CABGofdiffuseorheavilycalcifiedvessels).ACAREscore patients were randomized to the liberal group. We esti-
of4isdefinedaspatientswithanyuncontrolledmedical mated our sample size using computer software (PASS
problemandinwhomacomplexsurgeryisundertaken.17 2002,NCSS,Kaysville,UT).
Thesepatientswereselectedastransfusionratesinthese
individuals are high (e.g., reoperation, combined valve
RESULTS
andcoronaryarterysurgery,18-20renalinsufficiency18,21,22).
Patientswereexcludediftheyrefusedparticipation,were Aflowdiagramforthe50patientsrecruitedinthisstudy
unable to receive or refused blood products, or were demonstratedthatahighpercentageofindividualswere
involvedintheautologouspredonationprogram. noteligibleandaconsiderableproportiondeclinedpart-
icipation in the study (Fig.1). Enrollment rate was less
than1%.
Anesthesia and surgical management Thecharacteristicsofthepatientsaccordingtoallo-
All patients remained on their preoperative medications cation group are listed in Table1.There were no signifi-
asdirecteduntilthesurgicaldate.Patientswereanesthe- cant differences between the groups with regard to age,
tizedusinganarcotic(1-2mg/kgsufentanilor10-20mg/kg height, weight, and comorbid illnesses. Intraoperatively,
fentanyl),abenzodiazepine(0.1-0.15mg/kgmidazolam), thedurationofCPBandcross-clampingweresimilarfor
0.2%to1.5%isoflurane,and/or50-100mg/kg/minpropo- bothgroupsaswerethevolumeofestimatedintraopera-
fol,withmusclerelaxationprovidedfrom0.6to1.0mg/kg tive blood loss and the number of attempts to separate
rocuronium or 0.15mg/kg pancuronium. Heparin was fromCPB.Seventy-twopercentofpatientsintherestric-
giventomaintainanactivatedclottingtimeofmorethan tive group and 68% of patients in the liberal group were
420 seconds during CPB. Bypass management included usingantiplatelet(PLT)medicationsbeforesurgery.Anti-
nonpulsatilepumpflowof2.4¥bodysurfacearea,mean PLTmedicationstendedtobediscontinuedearlierinthe
Volume52,January2012 TRANSFUSION 93
SHEHATAETAL.
restrictivegroupthantheliberalgroupbutthisdifference
5757 patients had cardiac surgery (January 2007 to June
2010) didnotachievesignificance(median5days,IQR6daysvs.
median1day,IQR7days;p=0.9).Twenty-eightpercentof
patientsintherestrictivegroupand32%ofpatientsinthe
2753: Urgent/Emergent
liberal group were taking anticoagulants preoperatively.
1150: Not Care Score 3 or 4
624: Coordinator unavailable Allpatientsreceivedantifibrinolyticsexceptonepatientin
393: Other/Unknown therestrictivegroup.Twopatientsintherestrictivegroup
260: Enrolled in/Approached for
receivedaprotinin.
another study
188: Nonparticipating surgeon Overall, 13 patients were transfused 50 units in the
141: Unable to give consent (e.g. restrictivegroupcomparedto22(88%)patientswhowere
language barrier)
transfused99unitsofRBCsintheliberalgroup(p<0.01
29: Autologous predonation
for the number of units transfused). Intraoperatively, 14
RBC units were transfused to the restrictive group com-
paredto48unitsofRBCsadministeredtotheliberalgroup
(p<0.01) (Fig.3). Table2 illustrates the proportion of
219 patients approached patientstransfusedRBCs,plasma,andPLTs.
Table3 illustrates the adherence data. The median
numberofdaysofadherencetothetransfusionstrategy
was8days(IQR,12days)intherestrictivearmand6days
169 declined 50 were randomized
(IQR,3days)intheliberalarm(p=0.04).Adherencewas
participation
calculated as the proportion of triggers that resulted in
transfusions administered according to the transfusion
strategy(i.e.,belowtheHbtransfusionthresholdattained
25 25 andpatientwastransfused/transfusionthresholdattained
Liberal group Restrictive group
forallpatients).RBCunitstransfusedforexcessivebleed-
ingwerenotincludedinthecalculationofadherencedata
Fig.1.Flowdiagramforinclusionandexclusionofpatients.
as the protocol was suspended if a patient was rapidly
bleeding.If2unitsofRBCsweretrans-
fused after one Hb measurement, the
TABLE1.Characteristicsofpatientsaccordingtoallocationgroup* first unit was considered adherent if
theHbthresholdwasattained;however,
Restrictivestrategy Liberalstrategy
Characteristic (n=25) (n=25) the second unit was not considered
Age(years) 67.2(cid:2)11.2 68.8(cid:2)9.2 adherent because only one RBC unit
Male:female 17:8 20:5
was to be transfused for each trigger
Weight(kg) 88.2(cid:2)15.3 85.5(cid:2)17.5
Height(cm) 171.2(cid:2)8.3 170.9(cid:2)10.8 attained.Theadherencetable(Table3)
Surgicalprocedure also does not include data for units
CABG 13(52) 15(60)
transfusedintheabsenceofaknownHb
Valve 5(20) 1(4)
CombinedCABGandvalve 7(28) 9(36) concentration.Forpatientsallocatedto
Unstableangina 6(24) 8(32) the restrictive strategy, adherence was
Angina 9(36) 10(40)
69% in the operating room, 82% in the
Myocardialinfarction 9(36) 9(36)
Valvularheartdisease 11(44) 9(36) intensive care unit, and 100% on the
Hypertension 25(100) 23(92) ward. For the liberal group, adherence
Creatinine>140mmol/L 2(8) 3(12)
was40%intheoperatingroom,69%in
Congestiveheartfailure 4(16) 3(12)
Chronicobstructivepulmonarydisease 2(8) 4(16) the intensive care unit, and 14% on
Cerebrovascularaccident 3(12) 7(28) theward.Therewere10RBCunitsinthe
Diabetesmellitus 9(36) 12(48)
restrictive group and 3 units in the
CAREscore3 17(68) 15(60)
CAREscore4 3(12) 5(20) liberal group that were transfused in
Age>80years 5(20) 5(20) theabsenceofaHbtransfusionthresh-
DurationofCPB(min) 98.8(cid:2)44.6 96.8(cid:2)41.5
old being attained. Thus adherence
Durationofcross-clamp(min) 74.6(cid:2)40.3 74.2(cid:2)33.1
Estimatedintraoperativebloodloss(mL) 710.5(cid:2)165.5 646.2(cid:2)277.9 overallwas84%intherestrictivegroup
MorethanoneattempttoseparatefromCPB 1(4) 2(8) and41%intheliberalgroup.Reasonsfor
Pre-CPBHct 36.6(cid:2)5.8 37(cid:2)5
nonadherenceincludedpatientrefusal,
LowestHctonCPB 25.5(cid:2)2.8 24.8(cid:2)3.7
the use of hemoconcentration, hemor-
* Dataarereportedasnumber(%)ormean(cid:2)SD.Therewerenosignificantdifferences
betweenthegroups. rhage,theHctandnottheHbconcentra-
tionbeingusedtotransfusethepatient,
94 TRANSFUSION Volume52,January2012
ADHERENCETOTRANSFUSIONCRITERIA
confusion about the transfusion strategy and whether it secondarytopneumonia,pulmonaryembolism,andpul-
wastobeappliedontheward,hyperkalemia,thephysician monaryedema;twopatientsdiedfromsepticshock;and
planningtorepeatthecompletebloodcountbeforetrans- onepatienthadacerebrovascularaccident.Thecauseof
fusing the patient, and the perfusionist being occupied. deathofthepatientintheliberalgroupwascardiogenic
Therationalefornonadherencewasnotwelldescribedfor shock.
theremainderofthetransfusions.
ThemeanHbconcentrationsweresimilarpreopera-
DISCUSSION
tively but after surgery the Hb concentrations began to
diverge (Fig.2). The differences in Hb concentration This is the first randomized controlled trial in patients
increased as the hospital stay increased (p<0.01). The undergoingcardiacsurgerytofocusonadherenceratesto
meanHbconcentrationonDay6fortherestrictivegroup transfusionstrategiesinapatientpopulationwherethere
was 91.1g/L and for the liberal group 107.0g/L isvariabilityintransfusionpracticeandclinicalequipoise
(p=0.0004). inselectingtransfusionthresholds.Thetrendforreduced
The mixed venous oxygen saturation was measured adherenceintheliberalgroupsuggestsanunprovenbias
insomepatients(11patientsintheliberalgroupandfour that cardiac surgery patients require lower thresholds
patientsintherestrictivegroup)withapulmonaryartery which may have the potential to influence practice and
catheterasasignoftissuehypoxia(Fig.4).Therewereno studyoutcomes.Theimportanceofthedeterminationof
differencesinthemixedvenousoxygensaturationbefore adherenceratestotransfusionstrategiescannotbeunder-
orafterRBCtransfusionintherestrictiveorliberalgroup. stated because adherence rates can affect outcomes if a
Wedidnotdetectsignificantdifferencesinanyofthe considerableproportionofpatientsdonotreceiveatrans-
adverseoutcomes(Table4);however,thetotalnumberof fusionaccordingtotheirtransfusionstrategy.Experimen-
adverseeventswas38(includingdeath)intherestrictive taldatacanbedifficulttointerpretifahighproportionof
strategygroupcomparedto15intheliberalstrategy(OR, patientsdonotreceivetransfusionaccordingtothetrans-
6.4; 95% CI, 2.8-14.9). There were four deaths in the fusion threshold or if patients only receive a transfusion
restrictive group and one in the liberal group. In the during presumed critical periods of reduced oxygen
restrictivestrategy,onepatientdiedofrespiratoryfailure supply,thatis,intraoperativelyandintheintensivecare
unit. Adherence to transfusion strate-
giesshouldoccurthroughouttheentire
TABLE2.Proportionofpatientstransfusedbloodproductsand
recombinantfactorVIIa* hospital stay since changes in trans-
fusion practice may impact patient
Bloodproduct Restrictive(n=25) Liberal(n=25)
Intraoperative outcomesregardlessofwhenthetrans-
RBCs 6(24) 15(60) fusion was received in the periope-
PLTs 3(12) 4(16)
rative period. There is evidence that
Plasma 3(12) 3(12)
Cryoprecipitate 2(8) 0 preoperativeandintraoperativeanemia
FactorVIIa 0 0 and transfusion are associated with
Postoperatively†
increased adverse events and length of
RBCs
Intensivecareunit 11(44) 17(68) stay, and adverse events are increased
Ward 3(12) 4(16) bythenumberofRBCtransfusions.6,23,24
PLTs 1(4) 9(36)
The recently published single-
Plasma 2(8) 8(32)
Cryoprecipitate 0 1(4) center Transfusion Requirements after
FactorVIIa 0 0 Cardiac Surgery study (TRACS; a ran-
* Dataarereportedasnumber(%). domized controlled trial of two trans-
† TherewerenoplasmaorPLTtransfusionsadministeredontheward.Allofthese fusion strategies in cardiac surgery
transfusionswereadministeredintheintensivecareunit.
patients)highlightstheneedforrecruit-
p=0.01forpostoperativePLTtransfusion.Therewerenoothersignificantdifferences.
mentstrategiestoincreasethegeneral-
TABLE3.Adherencedata
Restrictive Liberal
Hblevel Operatingroom Intensivecareunit Ward Operatingroom Intensivecareunit Ward
Hbbelowthreshold
Patienttransfused 9 18 2 33 39 3
Patientnottransfused 4 4 0 51 17 18
Hbabovethreshold
Patientnottransfused 141 127 96 75 100 105
Patienttransfused 9 2 0 2 0 0
Volume52,January2012 TRANSFUSION 95
wardintheliberalgroupcouldconfoundastudyoftrans-
fusion.Thelackofadherencelikelyreflectsthepreference
for a restrictive transfusion strategy at our hospital and
patientpreferenceduetoeducationalinformationadmin-
isteredtothemabouttherisksoftransfusionduringhos-
pitalization.Theseadherenceratesarelowerthanwehad
anticipated and reflects the challenges of conducting
studiesintransfusionmedicineinthispatientpopulation
thatneedtobesurmounted.Forexample,asaresultofthis
study we will revise our consent form to highlight the
potentialriskofnotreceivingatransfusionandtheuncer-
taintyfortheneedoftransfusion.Inaddition,thelackof
adherence also reflects how adherence is defined and
calculated.
Fig.2.MeanHbconcentrationsduringhospitalizationaccord-
Although not our primary outcome, patients allo-
ingtothetransfusionstrategy.( )Liberal;( )restrictive.
cated to a lower Hb concentration experienced more
adverseevents.Thisoccurreddespitealackofsignificant
difference in the mixed venous oxygen saturation. It has
been well established that reduction in mixed venous
oxygen saturation is a poor surrogate of focal tissue
hypoxiaasfocalreductionsinvitalorganshavebeendem-
onstrated in the absence of changes in venous satura-
tion.27 In addition, the pilot study was not powered to
detectadifferenceinthemixedvenousoxygensaturation.
Nonetheless, the higher frequency of adverse events
potentiallyrelatedtotissueoxygendeliverysuggeststhat
further research is needed to determine if patients with
high-riskfeaturesmaybenefitfromhigherHbconcentra-
tionsfortransfusion.
Although theTRACS study did not find a significant
Fig.3.ProportionofpatientstransfusedRBCsaccordingto
difference in mortality between a Hb concentration of
thetransfusionstrategy.( )Restrictive;( )liberal.
80g/Lcomparedto100g/L,thetrialwasnotpoweredto
doso.Becausemortalityratesincardiacsurgeryarelow,
thousandsofpatientswouldneedtoberecruitedformor-
talityasaprimaryoutcome.25TRACSdidfindatrendtoan
increased risk of cardiogenic shock in patients random-
ized to a Hb concentration of 80g/L. There was also a
suggestionthatmortalitymaybeincreasedintherestric-
tivegroupbecausethehazardratioformortality,although
notsignificant,was1.28(95%CI,0.60-2.73);andthemor-
talityratefromDay18toDay28wasapproximately3%for
the liberal strategy but 5% for the restrictive strategy,
whichwouldbeaclinicallyimportantdifference.25
Thereareafewlimitationstothisstudy.Theenroll-
mentratewaslow;however,consideringthatpatientsare
sensitized to the risk of transfusion before surgery and
therewereseveralcompetingstudies,theseresultsarenot
unexpected.Futurestudiesneedtostresstheimportance
ofdeterminingthetransfusionthresholdsandthelackof
scientific evidence to support institutional transfusion
izability of results.25 Only a minority of patients are thresholdsinthispopulation.Theadherenceratesonthe
includedinrandomizedcontrolledtrials—28%ofpatients wardwerelowerthananticipated,likelyduetothepercep-
assessedinTRACSwereincludedinthatstudy.26 tionthatmostadverseeventssecondarytohypoxiawould
For both strategies there was a lower than accepted be anticipated to occur in the operating room or in the
adherencerate.Thelowproportionofadherenceonthe intensive care unit.This study was a pilot study and the
OVM
2
SHEHATAETAL.
90
80
70
60 Overall Mean
50
40
30
PRE POST
Pre/Posttransfusion
Fig.4.Mixedvenousoxygensaturation(MVO)levelspre-and
2
posttransfusioninasubsetofpatientsinthecardiovascular
intensivecareunit.
96 TRANSFUSION Volume52,January2012
ADHERENCETOTRANSFUSIONCRITERIA
canbeincorporatedinfuturestudiesto
TABLE 4.Postoperativecomplications* improve enrollment and recruitment
Adverseevent Restrictive(n=25) Liberal(n=25) rates. By addressing uncertainty sur-
Transfusionreaction 0 0 rounding transfusion thresholds and
Hemorrhage 1(4) 2(8)
overtransfusion, future studies may be
Pneumonia 4(16) 0
Useofinotropesformorethan24hr 4(16) 2(8) completedinatimelyfashion.However,
Sepsis 3(12) 0 additionalpilotstudiesneedtobecon-
Postoperativemyocardialinfarction 1(4) 0
ductedtoensureenrollmentandadher-
Greaterthan50%increaseinserumcreatinine 6(28) 5(20)
Dialysis 0 1(4) ence before a definitive randomized
Stroke 3(12) 0 controlledtrialisconducted.
Pulmonaryembolism/deepvenousthrombosis 1(4) 0
Thispilotstudydemonstratedthat
Multiorganfailure 1(4) 0
Reintubation 4(16) 1(4) there are physician and patient biases
Intubationmorethan48hr 5(20) 2(8) fortransfusionthresholdsandthatthere
Hospitalstaymorethan11days 9(36) 5(20)
isaneedforknowledgetranslation.The
Morethan4daysintheintensivecareunit 6(24) 3(12)
Death 4(16) 1(4) pilot study also demonstrated that the
Compositescore† 14(48) 8(32) adherence rates were sufficient in the
Lengthofhospitalstay(days) 9(cid:2)12 7(cid:2)4
operatingroomandintensivecareunit
* Dataarereportedasnumber(%)ormedian(cid:2)IQR.Therewerenostatisticallysignifi-
to separate Hb concentrations. Studies
cantdifferencesbetweenthegroups.
† Compositescore=neurologicevents,dialysisdependentrenalfailureorgreaterthan assessing transfusion strategies should
50%increaseincreatinine,prolongedlowoutputstate,andmyocardialinfarction. report adherence rates because adher-
encereflectstheproportionofpatients
transfusedaccordingtothetransfusion
resultant low adherence data can direct investigators in strategy and therefore compliance. Adherence will affect
futuretrialstoprovideappropriateeducationmaterialsto the interpretation of outcomes if a high proportion of
all individuals who participate in transfusion of these patientsarenottransfusedaccordingtothestrategy.This
patientstoensureadherencetotransfusionstrategies.This studyandtheTRACSstudyhighlighttheneedforalarge
studyincludedpatientswithhigh-riskfeaturesandthere- multicentered collaborative study to address transfusion
forecannotbeappliedtoallpatients.Therationaleforthe requirementsinthispatientpopulation.
selectionofthispopulationwasthatthispopulationwould
morelikelyreceiveatransfusionbecauseofahigherriskof ACKNOWLEDGMENTS
organinjuryandbecausetheyareagroupthatwouldmost
TheauthorswouldliketothankDrSusanBeloandDrBenSaxon
likely derive a benefit from the transfusion. Selecting a
fortheircontributionstotheDSMB,andMrDougMichaudand
homogenouspopulationpotentiallyalsoensurescompa-
MrSanjayYagnikfortheirassistancewithdatacollection.
rability.28ThechoiceoftriggersandrangeofHbconcen-
trationsselectedreflect1)thevaluesstudiedinthetrans-
CONFLICTOFINTEREST
fusiontriggersincriticalcaretrial;292)theneedtohavea
sufficientrangedifferencebetweenstrategiessoastohave
The authors declare that they have no conflicts of interest rel-
the potential to influence outcomes; 3) representative
evanttothemanuscriptsubmittedtoTRANSFUSION.
valueswithinthemarginofclinicalpracticeasestablished
bysurveys,variationstudies,andclinicalguidelines;304)
REFERENCES
rangesperceivedtobesafebytheinvestigatorsandexperts
inthefield;31,32and5)theclinicaluncertaintyofoptimum 1. HuttonB,FergussonD,TinmouthA,McIntyreL,KmeticA,
Hbconcentrationsfortransfusion.33-37 HebertPC.Transfusionratesvarysignificantlyamongst
Future studies of transfusion thresholds should Canadianmedicalcentres.CanJAnaesth2005;52:581-90.
include detailed information about enrollment and 2. Bennett-GuerreroE,ZhaoY,O’BrienSM,FergusonTBJr,
adherence rates. Adherence rates and the proportion of PetersonED,GammieJS,SongHK.Variationinuseof
individuals satisfying these adherence rates should be bloodtransfusionincoronaryarterybypassgraftsurgery.
reportedfortheentirehospitalization.An80%adherence JAMA2010;304:1568-75.
rate is acceptable as previous reports have attained this 3. CorwinHL,GettingerA,PearlRG,FikMP,LevyMM,
adherence rate,27,30 albeit not for the entire hospitaliza- AbrahamE,MacIntyreNR,ShabotMM,DuhMS,Shapiro
tion. By achieving this adherence rate a definitive study MJ.TheCRITstudy:anemiaandbloodtransfusioninthe
thatwillrequireatleast2000patientscanbecompleted criticallyill—currentclinicalpracticeintheUnitedStates.
andusedtoguideclinicalpractice. CritCareMed2004;32:39-52.
This study identified barriers to enrollment and 4. VincentJL,BaronJ-F,ReinhartK,GattioniL,ThijsL,Webb
recruitment so that methods to overcome these barriers A,Meier-HellmannA,NolletG,Peres-BotaD,ABC(Anemia
Volume52,January2012 TRANSFUSION 97
SHEHATAETAL.
andBloodTransfusioninCriticalCare)Investigators. controlledtrials.CochraneDatabaseSystRev2007;(2):
Anemiaandbloodtransfusionincriticallyillpatients. MR000021.
JAMA2002;288:1499-507. 16. RossS,GrantA,CounsellC,GillespieW,RussellI,Prescott
5. KarkoutiK,WijeysunderaDN,BeattieWS,ReducingBleed- R.Barrierstoparticipationinrandomisedcontrolledtrials:
inginCardiacSurgery(RBC)Investigators.Riskassociated asystematicreview.JClinEpidemiol1999;52:1143-56.
withpreoperativeanemiaincardiacsurgery:amulticenter 17. DupuisJY,WangF,NathanH,LamM,GrimesS,Bourke
cohortstudy.Circulation2008;117:478-84. M.Thecardiacanesthesiariskevaluationscore.Anesthesi-
6. ScottBH,SeifertFC,GrimsonR.Bloodtransfusionisasso- ology2001;94:194-204.
ciatedwithincreasedresourceutilisation,morbidityand 18. MagovernJA,SakertT,BenckartDH,BurkholderJA,
mortalityincardiacsurgery.AnnCardAnesth2008;11: LieblerGA,MagovernGJSr,MagovernGJJr.Amodelfor
15-9. predictingtransfusionaftercoronaryarterybypassgraft-
7. SurgenorSD,KramerRS,OlmsteadEM,RossCS,Sellke ing.AnnThoracSurg1996;61:27-32.
FW,LikoskyDS,MarrinCA,HelmREJr,LeavittBJ,Morton 19. MoskowitzDM,KleinJJ,ShanderA,CousineauKM,Gold-
JR,CharlesworthDC,CloughRA,HernandezF,Frumiento weitRS,BodianC,PerelmanSI,KangH,FinkDA,
C,BenakA,DioDataC,O’ConnorGT,NorthernNew RothmanHC,ErginMA.Predictorsoftransfusionrequire-
EnglandCardiovascularDiseaseStudyGroup.Theassocia- mentsforcardiacsurgicalproceduresatabloodconserva-
tionofperioperativeredbloodcelltransfusionsand tioncenter.AnnThoracSurg2004;77:626-34.
decreasedlong-termsurvivalaftercardiacsurgery.Anesth 20. LithmatheJ,BoekenU,FeindtP,GamsE.Predictorsof
Analg2009;108:1741-6. homologousbloodtransfusionforpatientsundergoing
8. KochCG,LiL,DuncanAI,MihaljevicT,CosgroveDM, openheartsurgery.ThoracCardiovascSurg2003;51:17-
LoopFD,StarrNJ,BlackstoneEH.Morbidityandmortality 21.
riskassociatedwithredbloodcellandblood-component 21. AroraRC,LegareJF,ButhKJ,SullivanJA,HirschGM.Iden-
transfusioninisolatedcoronaryarterybypassgrafting.Crit tifyingpatientsatriskofintraoperativeandpostoperative
CareMed2006;34:1608-16. transfusioninisolatedCABG:towardselectiveconserva-
9. KulierA,LevinJ,MoserR,Rumpold-SeitlingerG,TudorIC, tionstrategies.AnnThoracSurg2004;78:1547-55.
Snyder-RamosSA,MoehnleP,ManganoDT,Investigators 22. CovinR,O’BrienM,GrunwaldG,BrimhallB,SethiG,
oftheMulticenterStudyofPerioperativeIschemia WalczakS,ReiquamW,RajagopalanC,ShroyerAL.Factors
ResearchGroup;IschemiaResearchandEducationFoun- affectingtransfusionoffreshfrozenplasma,platelets,and
dation.Impactofpreoperativeanemiaonoutcomein redbloodcellsduringelectivecoronaryarterybypassgraft
patientsundergoingcoronaryarterybypassgraftsurgery. surgery.ArchPatholLabMed2003;127:415-23.
Circulation2007;116:471-9. 23. vanStratenAH,BekkerMW,SolimanHamadMA,van
10. FangWC,HelmRE,KriegerKH,RosengartTD,DuBisWJ, ZundertAA,MartensEJ,SchönbergerJP,deWolfAM.
SasonC,LesserML,IsomOW,GoldJP.Impactof Transfusionofredbloodcells:theimpactonshort-term
minimumhematocritduringcardiopulmonarybypasson andlong-termsurvivalaftercoronaryarterybypassgraft-
mortalityinpatientsundergoingcoronaryarterysurgery. ing,aten-yearfollow-up.InteractCardiovascThoracSurg
Circulation1997;96(SupplII):194-9. 2010;10:37-42.
11. HabibRH,ZachariasA,SchwannT,RiordanCJ,DuhamS, 24. SurgenorSD,DeFoeGR,FillingerMP,LikoskyDS,Groom
AamirS.Adverseeffectsoflowhematocritduingcardio- RC,ClarkC,HelmRE,KramerRS,LeavittBJ,KlempererJD,
pulmonarybypassintheadult:shouldcurrentpracticebe KrumholzCF,WestbrookBM,GalatisDJ,FrumientoC,
changed?JThoracCardiovascSurg2003;125:1438-50. RossCS,OlmsteadEM,O’ConnorGT.Intraoperativered
12. SpeissBD,LeyC,BodySC,SiegelLC,StoverEP,MaddiR, bloodcelltransfusionduringcoronaryarterybypassgraft
D’AmbraM,JainU,LiuF,HerskowitzA,ManganoDT, surgeryincreasestheriskofpostoperativelow-output
LevinJ.Hematocritvalueonintensivecareunitentry heartfailure.Circulation2006;114(Suppl):I43-8.
influencesthefrequencyofQ-wavemyocardialinfarction 25. HajjarLA,VincentJL,GalasFR,NakamuraRE,SilvaCM,
aftercoronaryarterybypassgrafting.JThoracCardiovasc SantosMH,FukushimaJ,KalilFilhoR,SierraDB,Lopes
Surg1999;116:46-467. NH,MauadT,RoquimAC,SundinMR,LeãoWC,Almeida
13. NelsonAH,FleisherLA,RosenbaumSH.Relationship JP,PomerantzeffPM,DallanLO,JateneFB,StolfNA,Auler
betweenpostoperativeanemiaandcardiacmorbidityin JOJr.Transfusionrequirementsaftercardiacsurgery:the
high-riskvascularpatientintheintensivecareunit.Crit TRACSrandomizedcontrolledtrial.JAMA2010;304:1559-
CareMed1993;21:860-6. 67.
14. LancasterGA,DoddS,WilliamsonPR.Designandanalysis 26. ShanderAS,GoodnoughLT.Bloodtransfusionasaquality
ofpilotstudies:recommendationsforgoodpractice.JEval indicatorincardiacsurgery.JAMA2010;304:1610-1.
ClinPract2004;10:307-12. 27. ColesJP,FryerTD,ColemanMR,SmielewskiP,GuptaAK,
15. RendellJM,MerrittRD,GeddesJR.Incentivesanddisin- MinhasPS,AigbirhioF,ChatfieldDA,WilliamsGB,Boni-
centivestoparticipationbycliniciansinrandomised faceS,CarpenterTA,ClarkJC,PickardJD,MenonDK.
98 TRANSFUSION Volume52,January2012
ADHERENCETOTRANSFUSIONCRITERIA
Hyperventilationfollowingheadinjury:effectonischemic anemiaimpairscognitivefunctionandmemoryin
burdenandcerebraloxidativemetabolism.CritCareMed humans.Anesthesiology2000;92:1646-52.
2007;35:568-78. 32. WeiskopfRB,VieleMK,FeinerJ,KelleyS,LiebermanJ,
28. DeansKJ,MinneciPC,SuffrediniAF,DannerRL,Hoffman NooraniM,LeungJM,FisherDM,MurrayWR,ToyP,
WD,CiuX,KleinHG,SchechterAN,BanksSM,Eichacker MooreMA.Humancardiovascularandmetabolicresponse
PQ,NatansonC.Randomizationinclinicaltrialsoftitrated toacutesevereisovolemicanemia.JAMA1998;279:217-21.
therapies:unintendedconsequencesofusingfixedtreat- 33. HebertPC,HuLQ,BiroGP.Reviewofphysiologicmecha-
mentprotocols.CritCareMed2007;35:1509-16. nismsinresponsetoanemia.CanMedAssocJ1997;
29. HebertPC,WellsG,BlajchmanMA,MarshallJ,MartinC, 156(Suppl):S27-S40.
PagliarelloG,TweeddaleM,SchweitzerI,YetisirE.Amulti- 34. WuWC,RathoreSS,WangY,RadfordMJ,KrumholzHM.
center,randomizedcontrolledclinicaltrialoftransfusion Bloodtransfusioninelderlypatientswithacutemyocardial
requirementsincriticalcare.NEnglJMed1999;340:409-17. infarction.NEnglMed2001;345:1230-6.
30. SocietyofThoracicSurgeonsBloodConservationGuide- 35. RaoSV,JollisJG,HarringtonRA,GrangerCB,NewbyLK,
lineTaskForce,FerrarisVA,FerrarisSP,SahaSP,HesselEA ArmstrongPW,MoliternoDJ,LindbladL,PieperK,Topol
2nd,HaanCK,RoystonBD,BridgesCR,HigginsRS,Des- EJ,StamlerJS,CaliffRM.Relationshipofbloodtransfusion
potisG,BrownJR;SocietyofCardiovascularAnesthesiolo- andclinicaloutcomesinpatientswithacutecoronarysyn-
gistsSpecialTaskForceonBloodTransfusion,SpiessBD, dromes.JAMA2004;292:1555-62.
Shore-LessersonL,Stafford-SmithM,MazerCD,Bennett- 36. AronsonD,DannEJ,BonsteinL,BlichM,KapeliovichM,
GuerreroE,HillSE,BodyS.Perioperativebloodtransfu- BeyarR,MarkiewiczW,HammermanH.Impactofred
sionandbloodconservationincardiacsurgery:The bloodcelltransfusiononclinicaloutcomesinpatientswith
SocietyofThoracicSurgeonsandTheSocietyofCardiovas- acutemyocardialinfarction.AmJCardiol2008;102:115-9.
cularAnesthesiologistsclinicalpracticeguideline.Ann 37. SinglaI,ZahidM,GoodCB,MacioceA,SonelAF.Impact
ThoracSurg2007;83(Suppl):S27-86. ofbloodtransfusionsinpatientspresentingwithanemia
31. WeiskopfRB,KramerJH,VieleM,NeumannM,FeinerJR, andsuspectedacutecoronarysyndrome.AmJCardiol
WatsonJMA,HopfHW,ToyP.Acutesevereisovolemic 2007;99:1119-21.
Volume52,January2012 TRANSFUSION 99
